Adaption and preliminary validation of the Addenbrooke's Cognitive Examination-III as a screening test for mild cognitive impairment and dementia in hearing-impaired individuals.

Courtney NorthMary H HeatleyNattawan UtoomprurkpornDoris Eva BamiouSergi G CostafredaJoshua Stott

Published in: European journal of neurology (2021)

Preliminarily, the HI-ACE-III showed good reliability, validity and screening utility for MCI and dementia in older adults in a hearing-impairment context. The adapted HI-ACE-III may offer accurate and reliable indication of cognitive performance, supporting timely diagnosis and research examining links between hearing loss and cognitive decline.

Keyphrases

mild cognitive impairment
cognitive decline
hearing loss
angiotensin converting enzyme
angiotensin ii
physical activity
high resolution